Médicament autorisé
Une autorité de régulation l'a homologué pour au moins une utilisation, dans au moins un pays. Cela ne dit rien des utilisations en dehors de cette homologation.
Cette page est une ébauche
The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.
Quelle est la solidité des preuves
Jusqu'où il a grimpé
Chaque médicament gravit la même échelle. La plupart des composés n'atteignent jamais le sommet, et la position d'un composé indique la solidité de ses allégations.
- Médicament autorisé: Teriparatide
Une autorité de réglementation a examiné les essais et l'a autorisé pour un usage précis.
- Phase 3
Grands essais randomisés, souvent des milliers de personnes, contre placebo ou traitement de référence.
- Phase 2
Essais de taille moyenne qui mesurent l'effet en fonction de la dose chez des personnes atteintes de la maladie.
- Phase 1 et premières études chez l'humain
Premières études chez l'humain : innocuité et manière dont l'organisme le traite.
- Cellules et animaux
Travaux en laboratoire et sur animaux. Un résultat chez l'animal n'est pas un résultat chez l'humain.
- 1,466
- articles sur PubMed
- 979
- dont chez l'humain
- 221
- essais randomisés
- 172
- revues
Un nombre indique la quantité de publications, et non ce qu'elles ont trouvé. Compté sur PubMed : 2026-11-16
Manipulation et reconstitution
De la poudre à un échantillon mesuré
Les mêmes quatre étapes pour tout flacon lyophilisé. Manipulation en laboratoire, et non utilisation chez une personne.
1. Lire le flacon
L'étiquette indique la masse de peptide contenue dans le flacon, en milligrammes. Ce nombre est le point de départ de chaque calcul.
2. Ajouter le diluant
Un volume mesuré de diluant est versé lentement, le long de la paroi du verre. Faites tourner doucement ; secouer peut endommager un peptide.
3. Calculer la concentration
La concentration est la masse divisée par le volume : 10 mg dans 2 mL donnent 5 mg par mL.
4. Mesurer l'échantillon
Le volume est la masse souhaitée divisée par la concentration. Sur une seringue U-100, 1 mL correspond à 100 unités.
Le calculateur ci-dessous effectue le calcul et montre son raisonnement.
As powder
General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.
In solution
Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.
This is general practice for lyophilized peptides, not data on Teriparatide itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage
Reconstitution calculator
Opens on vial sizes common for research peptides. Change any number. How the arithmetic works
Draw to
10 units
0.1 mL on a U-100 syringe
- Concentration
- 2.5 mg/mL
- Each unit holds
- 25 mcg
- Samples in the vial
- 20
- Sample
- 250 mcg
5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of Teriparatide; no amount here is a recommendation.
Teriparatide: sur PubMed
What PubMed held for Teriparatide on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.
- 1,466
- papers
- 979
- in humans
- 280
- clinical trials
- 221
- randomized trials
Most relevant on PubMed
Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.
- Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial
Randomized trialLeder BZ, Tsai JN, Uihlein AV, et al. Lancet (London, England), 2015. PMID 26144908
- Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Meta-analysisLi M, Ge Z, Zhang B, et al. Archives of osteoporosis, 2024. PMID 39312040
- Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial
Randomized trialTsai JN, Uihlein AV, Lee H, et al. Lancet (London, England), 2013. PMID 23683600
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
Randomized trialKendler DL, Marin F, Zerbini CAF, et al. Lancet (London, England), 2018. PMID 29129436
- Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
ReviewDavis S, Simpson E, Hamilton J, et al. Health technology assessment (Winchester, England), 2020. PMID 32588816
- Teriparatide Promotes Bone Healing in Medication-Related Osteonecrosis of the Jaw: A Placebo-Controlled, Randomized Trial
Randomized trialSim IW, Borromeo GL, Tsao C, et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2020. PMID 32614699
- Teriparatide
StudyVall H, Patel P, Parmar M , 2024. PMID 32644674
- Teriparatide
Review, 2012. PMID 31644031
Search used: ("Teriparatide"[ti]). Run it on PubMed
Liens de recherche
- PubMed (opens in a new tab)Every indexed paper, newest first
- ClinicalTrials.gov (opens in a new tab)Registered trials and their status
- Europe PMC (opens in a new tab)Full text where it is open access
- Google Scholar (opens in a new tab)Papers, preprints and who cites them
- PubChem (opens in a new tab)Structure, identifiers and properties
- YouTube (opens in a new tab)Talks and lectures. Check who is speaking
These open a search for Teriparatide on each site. The wiki has not reviewed what they return: a video or a preprint is not a peer-reviewed result, and none of it is medical advice.